<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02469480</url>
  </required_header>
  <id_info>
    <org_study_id>FERINJECT</org_study_id>
    <nct_id>NCT02469480</nct_id>
  </id_info>
  <brief_title>Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.</brief_title>
  <official_title>Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IKF Klinische Krebsforschung GmbH at Krankenhaus Nordwest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IKF Klinische Krebsforschung GmbH at Krankenhaus Nordwest</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Iron deficiency has a high prevalence in colorectal cancer patients ranging at ca. 60%. About
      70% of these patients suffer from iron deficiency anemia (IDA) which adds both physical and
      cognitive impediments to an already straining chemotherapy. Moreover, a chronic disease like
      cancer often results in a reduced availability of iron for the body. In clinical practice
      iron substitution is usually administered orally. Due to low resorption rates, frequent
      gastric side effects and thus poor patient compliance a parenteral substitution seems to be a
      better option in terms of efficacy. In the framework of a randomized multicenter clinical
      trial ('FerInject') a comparison of efficacy parameters of parenteral vs. oral iron
      substitution will now be conducted in order to identify the best treatment form for clinical
      practice in oncology. Furthermore detailed quality of life-data (QoL) will be collected in
      both treatment arms for effect comparison.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rise or normalization of hemoglobin</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatigue as measured by EORTC-QLQ-FA13</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life as measured by EORTC-C30</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Handgrip strength as measured by Hydraulic Hand Dynamometer</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of allogenic blood transfusions (in total and per patient)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until rise or normalisation of hemoglobin</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genesis of the iron deficiency anemia</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of therapy with recombinant erythropoietin</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose of therapy with recombinant erythropoietin</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of therapy with recombinant erythropoietin</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory parameters</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence nutritional status on iron deficiency anemia as measured by Nutritional Risk Screening (NRS 2002)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence nutritional status on therapy success as measured by Nutritional Risk Screening (NRS 2002)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dropout rate due to toxicity or patient will</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Metastatic Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>FERRIC CARBOXYMALTOSE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>max. 2.000 mg of ferric carboxymaltose over max. 2 weeks (max. 1.000 mg per week).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ferro sanol(R) duodenal 100 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 mg ferro sanol per day over 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>FerInject</intervention_name>
    <description>FerInject: max. 2.000 mg of ferric carboxymaltose over max. 2 weeks (max. 1.000 mg per week).</description>
    <arm_group_label>FERRIC CARBOXYMALTOSE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferro sanol</intervention_name>
    <description>200 mg ferro sanol per day over 12 weeks</description>
    <arm_group_label>ferro sanol(R) duodenal 100 mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Metastatic or inoperable colorectal carcinoma. No curative therapy available.

          2. Current palliative chemotherapy. Patients under conversion therapy must not be
             enrolled to this study.

          3. Iron deficiency anemia: hemoglobin ≤ 10.5 g/dl and transferrin saturation &lt; 20 %
             and/or serum ferritin &lt; 20 ng/ml

          4. Male and female patients aged ≥ 18 years; maturity

          5. ECOG ≤ 2

          6. Written informed consent

          7. Life expectancy &gt; 6 months

          8. Body weight ≥ 40 kg

        Exclusion Criteria:

          1. Oral or intravenous iron substitution within the last 4 weeks

          2. Age &lt; 18 years or body weight &lt; 40 kg

          3. Absorption dysfunction due to short bowel syndrome or after gastric resection

          4. Therapy with recombinant erythropoietin within the last 4 weeks

          5. Chronic diarrhea

          6. Chronic inflammatory bowel disease

          7. Ferritin &gt; 800 mg/dl at baseline

          8. Hypersensitivity or contraindication to ferric carboxymaltose or iron (II) glycine
             sulphate complex

          9. Known vitamin B12 or folic acid anemia

         10. Necessary total parenteral nutrition

         11. Participation in another interventional study

         12. Pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Salah-Eddin Al-Batran, Professor</last_name>
    <phone>+496976014420</phone>
    <email>albatran.salah@khnw.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gerrit zur Hausen, PhD</last_name>
    <phone>+496976014562</phone>
    <email>zurhausen.gerrit@khnw.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Krankenhaus Nordwest gGmbH - Institut of Clinical Cancer Research</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hesse</state>
        <zip>60488</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salah-Eddin Al-Batran, Professor</last_name>
      <phone>+496976014420</phone>
      <email>albatran.salah@khnw.de</email>
    </contact>
    <contact_backup>
      <last_name>Alexander Reichart, MD</last_name>
      <phone>+496976014350</phone>
      <email>reichart.alexander@khnw.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Klinikum Aschaffenburg</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W. Fischbach, Professor</last_name>
      <phone>+496021323521</phone>
      <email>wolfgang.fischbach@klinikum-aschaffenburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Christine Klassert</last_name>
      <phone>+496021323018</phone>
      <email>christine.klassert@klinikum-aschaffenburg.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Klinikum Bayreuth</name>
      <address>
        <city>Bayreuth</city>
        <zip>85445</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Armin A Leitner, MD</last_name>
      <phone>+49921400756352</phone>
      <email>armin.leitner@klinikum-bayreuth.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Augusta-Krankenanstalt gGmbH</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dirk Behringer, Professor</last_name>
      <phone>+492345172446</phone>
      <email>behringer@augusta-bochum.de</email>
    </contact>
    <contact_backup>
      <last_name>Dorothee Henzler</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitaetsklinik Bochum</name>
      <address>
        <city>Bochum</city>
        <zip>44892</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolf Schmiegel, Professor</last_name>
      <phone>+4923429980400</phone>
    </contact>
    <contact_backup>
      <last_name>Anke Lochter</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Dresden-Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harald Schmalenberg, MD</last_name>
      <phone>+493514804556</phone>
      <email>harald.schmalenberg@khdf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunnar Folprecht, MD</last_name>
      <phone>+49351-7965620</phone>
      <email>gunnar.folprecht@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kliniken Essen Mitte</name>
      <address>
        <city>Essen</city>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Müller, MD</last_name>
      <phone>+4920117424524</phone>
      <email>ch.mueller@kliniken-essen-mitte.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Waidmann, MD</last_name>
      <phone>+4969-630187788</phone>
      <email>Oliver.Waidmann@kgu.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Halle-Wittenberg</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Petra Büchner-Steudel, MD</last_name>
      <phone>+493455572668</phone>
      <email>Petra.buechner-steudel@uk-halle.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätskrankenhaus Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Quidde</last_name>
      <phone>+490741053343</phone>
      <email>j.quidde@uke.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NCT Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg M Haag, MD</last_name>
      <phone>+496221-56 3 8687</phone>
      <email>georgmartin.haag@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftsklinikum Mittelrhein GmbH</name>
      <address>
        <city>Koblenz</city>
        <zip>56068</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeth Fritz, MD</last_name>
      <phone>+492611371941</phone>
      <email>Elisabeth.fritz@stiftungsklinikum.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Hofheinz, Professor</last_name>
      <phone>+496213833258</phone>
      <email>ralf.hofheinz@med3.ma.uni-heidelberg.de</email>
    </contact>
    <contact_backup>
      <last_name>Renate Kapaun</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Klinikum rechts der Isar</name>
      <address>
        <city>Munich</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hana Algül, MD</last_name>
      <phone>+4989-4140 6706</phone>
      <email>hana.alguel@mri.tum.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Bogenhausen</name>
      <address>
        <city>Munich</city>
        <zip>81925</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Fuchs, MD</last_name>
      <phone>+4989-9270 2462</phone>
      <email>martin.fuchs@klinikum-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elblandklinikum Riesa</name>
      <address>
        <city>Riesa</city>
        <zip>01589</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Schubert, Prof.</last_name>
      <phone>+49352575 5697</phone>
      <email>Joerg.Schubert@elblandkliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Caritas Klinikum St. Theresia</name>
      <address>
        <city>Saarbrucken</city>
        <zip>66113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Clemens, Prof.</last_name>
      <phone>+49681-4061342</phone>
      <email>m.clemens@caritasklinikum.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.ikf-nordwest.de/home-studien.html?study=156</url>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2015</study_first_submitted>
  <study_first_submitted_qc>June 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2015</study_first_posted>
  <last_update_submitted>January 10, 2018</last_update_submitted>
  <last_update_submitted_qc>January 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MCRC</keyword>
  <keyword>iron substitution</keyword>
  <keyword>iron deficiency anemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Ferric Compounds</mesh_term>
    <mesh_term>Glycine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

